Generic pharmaceutical products provider Lannett Company (LCI) is a puzzle. Lannett shares jumped as much as 50% today, before trimming back some gains …
Small growth stocks can be packed with potential, but any discussion of the market’s fast-growing little guys usually comes with a couple of …
Lannett Company, Inc. (NYSE:LCI) is cashing in on the demand for generic drugs.
In a research report issued today, Canaccord Genuity analyst John Newman maintained a Buy rating on Lannett Company (NYSE:LCI) with a price target …
In a research report released today, Oppenheimer analyst Rohit Vanjani reiterated a Perform rating on Lannett Company (NYSE:LCI), while no price target was …
Roth Capital analyst Scott Henry maintained a Buy rating on Lannett Company (NYSE:LCI) with a price target of $66, as the company reported FY1Q15 …
This October has been one “spooky” month for the market. The underlying fundamentals of the market remain positive.
In a research report issued today, Oppenheimer analyst Rohit Vanjani maintained an Outperform rating on Lannett Company (NYSE:LCI) and slightly raised his price …
After a stellar 2013 and so-so first half of 2014, small-cap stocks ran into a wall in the third quarter. The Russell 2000 …
In a research report issued today, Roth Capital analyst Scott Henry maintained a Buy rating on Lannett Company (NYSE:LCI) and raised his price …
